APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mosapride

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mosapride Market Analysis and Forecast 2026-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchMosapride Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mosapride Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Mosapride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mosapride Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mosapride Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mosapride market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Mosapride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mosapride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mosapride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mosapride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Mosapride include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Mosapride, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mosapride, also provides the revenue of main regions and countries. Of the upcoming market potential for Mosapride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mosapride revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mosapride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mosapride revenue, projected growth trends, production technology, application and end-user industry.

Mosapride Segment by Company

DAIICHI SANKYO

Dainippon Pharmaceutical Co., Ltd.

Nihon Generic

NIPPON CHEMIPHAR CO., LTD.

SAWAI PHARMACEUTICAL CO., LTD.

Sumitomo Dainippon Pharma

Konghong Pharmaceutical

HAOSON PHARMA

Lunan Pharmaceutical Group

Mosapride Segment by Type

Tablet

Capsule

Others

Mosapride Segment by Application

Gastritis

Dyspepsia

Others

Mosapride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Mosapride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Mosapride company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mosapride revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mosapride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Player Table 3. Capsule Major Player Table 4. Others Major Player Table 5. Global Mosapride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gastritis Major Player Table 7. Dyspepsia Major Player Table 8. Others Major Player Table 9. Mosapride Industry Trends Table 10. Mosapride Industry Drivers Table 11. Mosapride Industry Opportunities and Challenges Table 12. Mosapride Industry Restraints Table 13. Global Mosapride Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Mosapride Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Mosapride Market Share by Region (2021-2026) Table 16. Global Mosapride Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Mosapride Market Share by Region (2027-2032) Table 18. Global Mosapride Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Mosapride Revenue Market Share by Players (2021-2026) Table 20. Global Mosapride Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Mosapride Key Players Headquarters & Area Served Table 22. Global Mosapride Players, Product Type & Application Table 23. Global Mosapride Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Mosapride by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Mosapride Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Mosapride Revenue Market Share by Type (2021-2026) Table 30. Global Mosapride Revenue Market Share by Type (2027-2032) Table 31. Global Mosapride Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Mosapride Revenue Market Share by Application (2021-2026) Table 35. Global Mosapride Revenue Market Share by Application (2027-2032) Table 36. DAIICHI SANKYO Company Information Table 37. DAIICHI SANKYO Business Overview Table 38. DAIICHI SANKYO Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. DAIICHI SANKYO Mosapride Product Portfolio Table 40. DAIICHI SANKYO Recent Development Table 41. Dainippon Pharmaceutical Co., Ltd. Company Information Table 42. Dainippon Pharmaceutical Co., Ltd. Business Overview Table 43. Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio Table 45. Dainippon Pharmaceutical Co., Ltd. Recent Development Table 46. Nihon Generic Company Information Table 47. Nihon Generic Business Overview Table 48. Nihon Generic Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Nihon Generic Mosapride Product Portfolio Table 50. Nihon Generic Recent Development Table 51. NIPPON CHEMIPHAR CO., LTD. Company Information Table 52. NIPPON CHEMIPHAR CO., LTD. Business Overview Table 53. NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio Table 55. NIPPON CHEMIPHAR CO., LTD. Recent Development Table 56. SAWAI PHARMACEUTICAL CO., LTD. Company Information Table 57. SAWAI PHARMACEUTICAL CO., LTD. Business Overview Table 58. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio Table 60. SAWAI PHARMACEUTICAL CO., LTD. Recent Development Table 61. Sumitomo Dainippon Pharma Company Information Table 62. Sumitomo Dainippon Pharma Business Overview Table 63. Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sumitomo Dainippon Pharma Mosapride Product Portfolio Table 65. Sumitomo Dainippon Pharma Recent Development Table 66. Konghong Pharmaceutical Company Information Table 67. Konghong Pharmaceutical Business Overview Table 68. Konghong Pharmaceutical Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Konghong Pharmaceutical Mosapride Product Portfolio Table 70. Konghong Pharmaceutical Recent Development Table 71. HAOSON PHARMA Company Information Table 72. HAOSON PHARMA Business Overview Table 73. HAOSON PHARMA Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. HAOSON PHARMA Mosapride Product Portfolio Table 75. HAOSON PHARMA Recent Development Table 76. Lunan Pharmaceutical Group Company Information Table 77. Lunan Pharmaceutical Group Business Overview Table 78. Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Lunan Pharmaceutical Group Mosapride Product Portfolio Table 80. Lunan Pharmaceutical Group Recent Development Table 81. North America Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Mosapride Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Mosapride Revenue by Country (2021-2026) & (US$ Million) Table 87. North America Mosapride Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Mosapride Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Mosapride Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe Mosapride Revenue by Country (US$ Million) & (2027-2032) Table 95. China Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 96. China Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 97. China Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 98. China Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Mosapride Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Mosapride Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia Mosapride Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA Mosapride Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA Mosapride Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA Mosapride Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA Mosapride Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA Mosapride Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA Mosapride Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA Mosapride Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Mosapride Image Figure 2. Global Mosapride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mosapride Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsule Image Figure 6. Others Image Figure 7. Global Mosapride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Mosapride Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gastritis Image Figure 10. Dyspepsia Image Figure 11. Others Image Figure 12. Global Mosapride Market Size (US$ Million) & (2021-2032) Figure 13. Global Mosapride Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Mosapride Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Mosapride Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Mosapride Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Mosapride Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Mosapride Revenue Market Share by Type (2021-2032) Figure 20. Global Mosapride Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Mosapride Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Mosapride Revenue Market Share by Application (2021-2032) Figure 23. North America Mosapride Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Mosapride Revenue Share by Type (2021-2032) Figure 25. North America Mosapride Revenue Share by Application (2021-2032) Figure 26. North America Mosapride Revenue Share by Country (2021-2032) Figure 27. United States Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Mosapride Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Mosapride Revenue Share by Type (2021-2032) Figure 32. Europe Mosapride Revenue Share by Application (2021-2032) Figure 33. Europe Mosapride Revenue Share by Country (2021-2032) Figure 34. Germany Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Mosapride Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Mosapride Revenue Share by Type (2021-2032) Figure 44. China Mosapride Revenue Share by Application (2021-2032) Figure 45. Asia Mosapride Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Mosapride Revenue Share by Type (2021-2032) Figure 47. Asia Mosapride Revenue Share by Application (2021-2032) Figure 48. Asia Mosapride Revenue Share by Region (2021-2032) Figure 49. Japan Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Mosapride Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Mosapride Revenue Share by Type (2021-2032) Figure 57. SAMEA Mosapride Revenue Share by Application (2021-2032) Figure 58. SAMEA Mosapride Revenue Share by Country (2021-2032) Figure 59. Brazil Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Mosapride Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Others
Applications
  • Gastritis
  • Dyspepsia
  • Others
Companies covered
  • DAIICHI SANKYO
  • Dainippon Pharmaceutical Co., Ltd.
  • Nihon Generic
  • NIPPON CHEMIPHAR CO., LTD.
  • SAWAI PHARMACEUTICAL CO., LTD.
  • Sumitomo Dainippon Pharma
  • Konghong Pharmaceutical
  • HAOSON PHARMA
  • Lunan Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mosapride Market by Type
  3. 1.2.1 Global Mosapride Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsule
  6. 1.2.4 Others
  7. 1.3 Mosapride Market by Application
  8. 1.3.1 Global Mosapride Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gastritis
  10. 1.3.3 Dyspepsia
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Mosapride Market Dynamics
  1. 2.1 Mosapride Industry Trends
  2. 2.2 Mosapride Industry Drivers
  3. 2.3 Mosapride Industry Opportunities and Challenges
  4. 2.4 Mosapride Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Mosapride Market Perspective (2021-2032)
  2. 3.2 Global Mosapride Growth Trends by Region
  3. 3.2.1 Global Mosapride Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mosapride Market Size by Region (2021-2026)
  5. 3.2.3 Global Mosapride Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Mosapride Revenue by Players
  2. 4.1.1 Global Mosapride Revenue by Players (2021-2026)
  3. 4.1.2 Global Mosapride Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Mosapride Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mosapride Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Mosapride Key Players Headquarters & Area Served
  7. 4.4 Global Mosapride Players, Product Type & Application
  8. 4.5 Global Mosapride Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Mosapride Market CR5 and HHI
  11. 4.6.3 2025 Mosapride Tier 1, Tier 2, and Tier 3
5 Mosapride Market Size by Type
  1. 5.1 Global Mosapride Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Mosapride Revenue by Type (2021-2032)
  3. 5.3 Global Mosapride Revenue Market Share by Type (2021-2032)
6 Mosapride Market Size by Application
  1. 6.1 Global Mosapride Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Mosapride Revenue by Application (2021-2032)
  3. 6.3 Global Mosapride Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 DAIICHI SANKYO
  2. 7.1.1 DAIICHI SANKYO Company Information
  3. 7.1.2 DAIICHI SANKYO Business Overview
  4. 7.1.3 DAIICHI SANKYO Mosapride Revenue and Gross Margin (2021-2026)
  5. 7.1.4 DAIICHI SANKYO Mosapride Product Portfolio
  6. 7.1.5 DAIICHI SANKYO Recent Developments
  7. 7.2 Dainippon Pharmaceutical Co., Ltd.
  8. 7.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
  12. 7.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Nihon Generic
  14. 7.3.1 Nihon Generic Company Information
  15. 7.3.2 Nihon Generic Business Overview
  16. 7.3.3 Nihon Generic Mosapride Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Nihon Generic Mosapride Product Portfolio
  18. 7.3.5 Nihon Generic Recent Developments
  19. 7.4 NIPPON CHEMIPHAR CO., LTD.
  20. 7.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
  21. 7.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
  22. 7.4.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (2021-2026)
  23. 7.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
  24. 7.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
  25. 7.5 SAWAI PHARMACEUTICAL CO., LTD.
  26. 7.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
  27. 7.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
  28. 7.5.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
  30. 7.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
  31. 7.6 Sumitomo Dainippon Pharma
  32. 7.6.1 Sumitomo Dainippon Pharma Company Information
  33. 7.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 7.6.3 Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
  36. 7.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 7.7 Konghong Pharmaceutical
  38. 7.7.1 Konghong Pharmaceutical Company Information
  39. 7.7.2 Konghong Pharmaceutical Business Overview
  40. 7.7.3 Konghong Pharmaceutical Mosapride Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
  42. 7.7.5 Konghong Pharmaceutical Recent Developments
  43. 7.8 HAOSON PHARMA
  44. 7.8.1 HAOSON PHARMA Company Information
  45. 7.8.2 HAOSON PHARMA Business Overview
  46. 7.8.3 HAOSON PHARMA Mosapride Revenue and Gross Margin (2021-2026)
  47. 7.8.4 HAOSON PHARMA Mosapride Product Portfolio
  48. 7.8.5 HAOSON PHARMA Recent Developments
  49. 7.9 Lunan Pharmaceutical Group
  50. 7.9.1 Lunan Pharmaceutical Group Company Information
  51. 7.9.2 Lunan Pharmaceutical Group Business Overview
  52. 7.9.3 Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
  54. 7.9.5 Lunan Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Mosapride Revenue (2021-2032)
  2. 8.2 North America Mosapride Revenue by Type (2021-2032)
  3. 8.2.1 North America Mosapride Revenue by Type (2021-2026)
  4. 8.2.2 North America Mosapride Revenue by Type (2027-2032)
  5. 8.3 North America Mosapride Revenue Share by Type (2021-2032)
  6. 8.4 North America Mosapride Revenue by Application (2021-2032)
  7. 8.4.1 North America Mosapride Revenue by Application (2021-2026)
  8. 8.4.2 North America Mosapride Revenue by Application (2027-2032)
  9. 8.5 North America Mosapride Revenue Share by Application (2021-2032)
  10. 8.6 North America Mosapride Revenue by Country
  11. 8.6.1 North America Mosapride Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Mosapride Revenue by Country (2021-2026)
  13. 8.6.3 North America Mosapride Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Mosapride Revenue (2021-2032)
  2. 9.2 Europe Mosapride Revenue by Type (2021-2032)
  3. 9.2.1 Europe Mosapride Revenue by Type (2021-2026)
  4. 9.2.2 Europe Mosapride Revenue by Type (2027-2032)
  5. 9.3 Europe Mosapride Revenue Share by Type (2021-2032)
  6. 9.4 Europe Mosapride Revenue by Application (2021-2032)
  7. 9.4.1 Europe Mosapride Revenue by Application (2021-2026)
  8. 9.4.2 Europe Mosapride Revenue by Application (2027-2032)
  9. 9.5 Europe Mosapride Revenue Share by Application (2021-2032)
  10. 9.6 Europe Mosapride Revenue by Country
  11. 9.6.1 Europe Mosapride Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Mosapride Revenue by Country (2021-2026)
  13. 9.6.3 Europe Mosapride Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Mosapride Revenue (2021-2032)
  2. 10.2 China Mosapride Revenue by Type (2021-2032)
  3. 10.2.1 China Mosapride Revenue by Type (2021-2026)
  4. 10.2.2 China Mosapride Revenue by Type (2027-2032)
  5. 10.3 China Mosapride Revenue Share by Type (2021-2032)
  6. 10.4 China Mosapride Revenue by Application (2021-2032)
  7. 10.4.1 China Mosapride Revenue by Application (2021-2026)
  8. 10.4.2 China Mosapride Revenue by Application (2027-2032)
  9. 10.5 China Mosapride Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mosapride Revenue (2021-2032)
  2. 11.2 Asia Mosapride Revenue by Type (2021-2032)
  3. 11.2.1 Asia Mosapride Revenue by Type (2021-2026)
  4. 11.2.2 Asia Mosapride Revenue by Type (2027-2032)
  5. 11.3 Asia Mosapride Revenue Share by Type (2021-2032)
  6. 11.4 Asia Mosapride Revenue by Application (2021-2032)
  7. 11.4.1 Asia Mosapride Revenue by Application (2021-2026)
  8. 11.4.2 Asia Mosapride Revenue by Application (2027-2032)
  9. 11.5 Asia Mosapride Revenue Share by Application (2021-2032)
  10. 11.6 Asia Mosapride Revenue by Country
  11. 11.6.1 Asia Mosapride Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Mosapride Revenue by Country (2021-2026)
  13. 11.6.3 Asia Mosapride Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mosapride Revenue (2021-2032)
  2. 12.2 SAMEA Mosapride Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Mosapride Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Mosapride Revenue by Type (2027-2032)
  5. 12.3 SAMEA Mosapride Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Mosapride Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Mosapride Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Mosapride Revenue by Application (2027-2032)
  9. 12.5 SAMEA Mosapride Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Mosapride Revenue by Country
  11. 12.6.1 SAMEA Mosapride Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Mosapride Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Mosapride Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst